The importance of rs1021737 and rs482843 polymorphisms of cystathionine gammalyase in the etiology of preeclampsia in the Caucasian population

Ginekologia Polska

Volumn 86, Issue 2, 2015, Pages 119-125

  Mrozikiewicz, Przemysław M ^a,b   Bogacz, Anna ^a,b   Omielańczyk, Magdalena ^a   Wolski, Hubert ^a,c   Bartkowiak Wieczorek, Joanna ^a,b   Grześkowiak, Edmund ^a   Czerny, Bogusław ^b,d   Drews, Krzysztof ^a   Seremak Mrozikiewicz, Agnieszka ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

^c Division of Gynecology and Obstetrics Podhale Multidisciplinary Hospital   (Poland)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cystathionine gamma lyase; Genetic polymorphism; Hydrogen sulfide; Preeclampsia

Indexed keywords

CYSTATHIONINE GAMMA LYASE;

ADULT; CASE CONTROL STUDY; CAUCASIAN; COMPARATIVE STUDY; FEMALE; FETOMATERNAL TRANSFUSION; GENETIC POLYMORPHISM; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CYSTATHIONINE GAMMA-LYASE; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; POINT MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PRENATAL CARE; YOUNG ADULT;

EID: 84928948514     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: 10.17772/gp/1998     Document Type: Article

References (31)

1. Seremak-Mrozikiewicz A, Dubiel M, Drews K, [et al.]. 1166C mutation of angiotensin II type 1 receptor gene is correlated with umbilical blood flow velocimetry in women with preeclampsia. J Matern Fetal Neonatal Med. 2005, 17, 117-1121.
2. Seremak-Mrozikiewicz A, Drews K, Barlik M, [et al.]. The significance of -786T > C polymorphism of endothelial NO synthase (eNOS) gene in severe preeclampsia. J Matern Fetal Neonatal Med. 2011, 24, 432-436. doi: 10.3109/14767058.2010.511329.
3. Bogacz A, Mrozikiewicz PM, Deka-Pawlik D, [et al.]. Frequency of G2677T/A and C3435T polymorphisms of MDR1 gene in preeclamptic women. Ginekol Pol. 2013, 84, 781-787.
4. Bryan S. Yang G, Wang R, [et al.]. Cystathionine gamma-lyase-deficient smooth muscle cells exhibit redox imbalance and apoptosis under hypoxic stress conditions. Exp Clin Cardiol. 2011, 16, 36-41.
5. Yang G, Wu L, Jiang B, [et al.]. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008, 322, 587-590.
6. Papapetropoulosa A, Pyriochoua A, Altaanyb Z, [et al.]. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA. 2009, 106, 21972-21977.
7. Wang R. Signaling pathways for the vascular effects of hydrogen sulfide. Curr Opin Nephrol Hypertens. 2011, 20, 107-112.
8. Qiao W, Chuoshu T, Hongfang J, [et al.]. Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochem Biophys Res Commun. 2010, 396, 182-186.
9. Bełtowski J. Hydrogen sulfide as a biologically active mediator in the cardiovascular system. Postepy Hig Med Dosw. 2004, 58, 285-291.
10. Yamada H, Akahoshi, Kamata S, [et al.]. Methionine excess in diet induces acute lethal hepatitis in mice lacking cystathionine -lyase. an animal model of cystathioninuria. Free Radic Biol Med. 2012, 52, 1716-1726.
11. Kimura GA, Squadrito GL, Mills RW, [et al.]. Hydrogen sulfide its production, release and function. Amino Acids .2011, 41, 113-123.
12. Kokot F, Hyla-Klekot L, Ficek R. Hydrogen sulphide - is it an important, apart from nitric oxide and carbon oxide, gaseous transmitter in human. Arterial Hypertension. 2012, 16, 120-124.
13. Chen X, Jhec K, Kruger WD. Production of the neuromodulator H2S by cystathionin-betasynthase via the condensation of cysteine and homocysteine. J Biol Chem. 2004, 279, 52082-52086.
14. Donald LJ, Wang HS, Hamerton JL. Assignment of the gene for cystathionase (CYS) to human chromosome 16. Cytogenet Cell Genet. 1982, 32, 268.
15. Wang J. Hegele RA. Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH). Hum Genet. 2003, 112, 404-408.
16. Whiterman M, Moose PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J Cell Mol Med. 2009, 13, 488-507.
17. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Chronic hypertension in pregnancy. ACOG Committee on Practice Bulletins. Obstet Gynecol. 2001, 98, 177-185.
18. Li Y, Zhao Q, Liu XL, [et al.]. Relationship between cystathionine -lyase gene polymorphism and essential hypertension in Northern Chinese Han population. Chin Med J. 2008, 121, 716-720.
19. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996, 16, 1066-1071.
20. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun. 2000, 267, 129-133.
21. Dello Russo C, Tringali G, Ragazzoni E, [et al.]. Evidence that hydrogen sulphide can modulate hypothalamo-pituitary-adrenal axis function: in vitro and in vivo studies in the rat. J Neuroendocrinol. 2000, 12, 225-233.
22. Zhao W, Zhang J, Lu Y, [et al.]. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J. 2001, 20, 6008-6016.
23. Sen U, Mishra PK, Tyagi N, [et al.]. Homocysteine to hydrogen sulfide or hypertension. Cell Biochem Biophys. 2010, 57, 49-58.
24. Perna AF, Ingrosso D, Violetti E, [et al.]. Hyperhomocysteinemia in uraemia - a red flag in a disrupted circuit. Semin Dial. 2009, 22, 351-356.
25. Wang J, Huff AM, Spence JD, [et al.]. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration. Clin Genet. 2004, 65, 483-486.
26. Lucock M, Yates Z, Martin C, [et al.]. Hydrogen sulphide-related thiol metabolism and nutrigenetics in relation to hypertension in an elderly population. Genes Nutr. 2013, 8, 221-229.
27. Kraus JP, Hasek J, Kozich V, [et al.]. Cystathionine gamma-lyase: Clinical, metabolic, genetic, and structural studies. Mol Genet Metab. 2009, 97, 250-259.
28. Zhu W, Lin A, Banerjee R. Kinetic properties of polymorphic variants and pathogenic mutants in human cystathionine -lyase. Biochemistr. 2008, 47, 6226-6232.
29. Wang K, Ahmad S, Cai M, [et al.]. Dysregulation of hydrogen sulfide producing enzyme cystathionine -lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation. 2013, 127, 2514-2522.
30. Cindrova-Davies T, Herrera EA, Niu Y, [et al.]. Reduced cystathionine -lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol. 2013, 182, 1448-1458.
31. Holwerda KM, Bos EM, Rajakumar A, [et al.]. Hydrogen sulfide producing enzymes in pregnancy and preeclampsia. Placenta. 2012, 33, 518-521.